| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/23/2009 | CN101537184A Composition containing water-insoluble high-activity drug and preparation method thereof |
| 09/23/2009 | CN101537183A Livestock cefquinome solution containing hexacyclic water |
| 09/23/2009 | CN101537177A Drug with thrombus-curing function and preparation method thereof |
| 09/23/2009 | CN101537174A Health preserving calcium |
| 09/23/2009 | CN101537173A Preparations stabilized over long time |
| 09/23/2009 | CN101537162A Chinese traditional medicine for curing Type II diabetes mellitus |
| 09/23/2009 | CN101537119A Chinese traditional medicine preparation for curing diabetes mellitus |
| 09/23/2009 | CN101537037A Amaranth berberine tablet and preparation method thereof |
| 09/23/2009 | CN101537030A Paste for treating physical trauma |
| 09/23/2009 | CN101537026A Xuesaitong dispersible tablet and preparation method thereof |
| 09/23/2009 | CN101537016A Compound microcapsule preparation containing cartilage cells of epiphyseal plate, preparation method and application thereof |
| 09/23/2009 | CN101537012A Complex vitamin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101537010A Eyedrop preparation and preparation method thereof |
| 09/23/2009 | CN101537008A Livestock cefquinome bletilla striata bioadhesive slow-release capsules |
| 09/23/2009 | CN101537002A Diacerein composition with good leaching property, and preparation and use thereof |
| 09/23/2009 | CN101536995A High imbibition dissoluble drug release external contraceptive membrane |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536990A Colchicines gastric floating sustained-release tablet and method for preparing same |
| 09/23/2009 | CN101536988A Troxerutin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101536987A Sodium alginate microballoon vein suppository containing hemangioma-resisting medicant, preparation method and application thereof |
| 09/23/2009 | CN101536986A Sodium alginate targeted sustained release microsphere vascular occlusive agent containing Sorafenib as well as preparation and application thereof |
| 09/23/2009 | CN101536985A Livestock cefquinome lung-targeted microspheres and preparation method thereof |
| 09/23/2009 | CN101536984A Injection-use recombinant human Endostatin porous sustained-release microsphere and preparation method thereof |
| 09/23/2009 | CN101536983A Albendazole oxide hydrochloride premix for animals |
| 09/23/2009 | CN101536982A Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof |
| 09/23/2009 | CN101536979A Edaravone lipid microsphere formulation and preparation method |
| 09/23/2009 | CN101536977A Gel taking 3 beta, 12, 13- trihydroxy- oleanane-28-acid as active ingredient |
| 09/23/2009 | CN101536976A Gel taking 1- acetoxyl group-28- dihydroxy- oleanane-2, 12- diene as active ingredient |
| 09/23/2009 | CN101536975A Gel taking 1, 28- dihydroxy- oleanane-2, 12- diene as active ingredient |
| 09/23/2009 | CN101536966A Dispersion of polymer particles, composition comprising same and cosmetic treatment method |
| 09/23/2009 | CN100543036C Targeting proteins to deliver therapeutic or diagnostic reagents |
| 09/23/2009 | CN100542613C Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542611C Aqueous preparation for injecting containing recombinant human serum albumin-interferon alpha fusion protein |
| 09/23/2009 | CN100542610C Solution for ungual and peri-ungual and its application in preparing medicine for mycosis |
| 09/23/2009 | CN100542609C Compositions comprising dietary fat complex and methods for their use |
| 09/23/2009 | CN100542538C Matrix film tablet with controlled release a natural mixture of conjugated estrogens |
| 09/22/2009 | US7592418 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eye for minimal invasive surgery; crosslinked synthetic polymer having electrophilic functional groups and dilysine, trilysine or tetralysine; dyes provide green color |
| 09/22/2009 | US7592372 Mixture of fudostein, acid and sweetening |
| 09/22/2009 | US7592341 Peptide-enhanced corneal drug delivery |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/22/2009 | US7592328 Natural cyclodextrin complexes |
| 09/22/2009 | US7592307 Releasable linkage and compositions containing same |
| 09/22/2009 | US7592300 Skin cleaning compounds, body splash, surgical scrub, wound care agents, hand sanitizers, disinfectants, mouthwashes, pet shampoos, hard surface sanitizer; reduction of bacteria, rotavirus, or rhinovirus on skin surface; topical |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592012 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 09/22/2009 | US7592005 Multiple myeloma; targeting antibody conjugated with a radionuclide or other cytotoxic substance |
| 09/22/2009 | US7592004 Lyophilizing an aqueous formulation comprising a high concentration, 50 mg/ml or more of an immunoglobulin IgG antibody, in particular, daclizumab, in 5-25 mM histidine buffer, having pH 5.5-6.5, 0.005%-0.03% polysorbate, and sucrose |
| 09/22/2009 | US7591995 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/22/2009 | US7591993 Microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2432534C Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2369451C Composition based on oppositely-charged polypeptides |
| 09/22/2009 | CA2360419C Molecules for the treatment and diagnosis of tumours |
| 09/22/2009 | CA2353604C Polymeric coatings for controlled delivery of active agents |
| 09/22/2009 | CA2331284C Solution comprising prostaglandins and benzyl alcohol |
| 09/22/2009 | CA2223703C Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 09/22/2009 | CA2110370C Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications |
| 09/17/2009 | WO2009114854A1 Biodegradable cross-linked branched poly (alkylene imines) |
| 09/17/2009 | WO2009114521A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | WO2009114520A2 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 09/17/2009 | WO2009114153A1 Oligomer-foscarnet conjugates |
| 09/17/2009 | WO2009114151A1 Oligomer-amino acid and olgomer-atazanavir conjugates |
| 09/17/2009 | WO2009113910A1 Antiinflammatory and antiallergic gel |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113578A1 Carbonyl compound remover |
| 09/17/2009 | WO2009113522A1 Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both |
| 09/17/2009 | WO2009113504A1 Patch |
| 09/17/2009 | WO2009113438A1 Antibacterial composition for medical use and medical device |
| 09/17/2009 | WO2009113420A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 09/17/2009 | WO2009113070A1 Freeze-free method for storage of polypeptides |
| 09/17/2009 | WO2009112874A1 Modified release composition comprising doxofylline |
| 09/17/2009 | WO2009112800A1 Losartan composition |
| 09/17/2009 | WO2009112769A2 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration |
| 09/17/2009 | WO2009112740A2 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/17/2009 | WO2009112682A1 Encapsulation of vitamin c into water soluble dendrimers |
| 09/17/2009 | WO2009112436A1 Modified release composition comprising doxofylline |
| 09/17/2009 | WO2009112402A1 Polymer derived from linear polyethylenimine for gene transfer |
| 09/17/2009 | WO2009085766A3 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 09/17/2009 | WO2009052491A3 Fenoldopam formulations and prodrug derivatives |
| 09/17/2009 | WO2008101179A8 Use of sucrose to suppress mannitol-induced protein aggregation |
| 09/17/2009 | WO2004039335A3 Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor |
| 09/17/2009 | US20090234070 Water-Soluble Polymer Alkanals |
| 09/17/2009 | US20090234027 Topical gel cosmetic formulation of cellacefate for the control of acne and rosacea |
| 09/17/2009 | US20090234026 Free of organic solvents and wherein fibroin solution is produced by process comprising dialyzing aqueous silk fibroin solution against hygroscopic polymer for sufficient time to result in aqueous fibroin solution of at least 10 wt %, wherein hygroscopic polymer has a molecular weight of 8,000 g/mol |
| 09/17/2009 | US20090234025 Protective Surface Film for a Liquid |
| 09/17/2009 | US20090233887 Hydroswellable, Segmented, Aliphatic Polyurethanes and Polyurethane Ureas |
| 09/17/2009 | US20090233871 Complexed polypeptide and adjuvant for improved vaccines |
| 09/17/2009 | US20090233847 Coupling Proteins to a Modified Polysaccharide |
| 09/17/2009 | US20090232896 Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions |
| 09/17/2009 | US20090232887 Pharmaceutical composition having reduced abuse potential |
| 09/17/2009 | US20090232865 End-Capped Poly(Ester Amide) Copolymers |
| 09/17/2009 | US20090232858 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/17/2009 | US20090232855 Percutaneous controlled releasing material using nano-sized polymer particles and external application agent containing the same |
| 09/17/2009 | US20090232835 Composition for delivery of hematopoietic growth factor |
| 09/17/2009 | US20090232762 Compositions for delivery of therapeutic agents |
| 09/17/2009 | US20090232753 Gel compositions |
| 09/17/2009 | US20090232752 Silicone polyurethane blends |